NEW YORK (GenomeWeb) – Genomic analysis software maker BioDiscovery said today it will use a $157,000 grant from the National Cancer Institute to analyze and improve copy number variant data from The Cancer Genome Atlas program.

The Small Business Innovation Research grant will fund efforts to develop and commercialize CNV and sequence variant data that researchers will use in studies of tumorigenesis and disease progression, and which will provide a validation set for use in international studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.